🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the efficacy and safety of Disitamb Vedotin combined with pyrotini...
Status
Recruiting
Location
Jiangsu Provincial People's Hospital
Start Date
2023-11-01
Trial ID
NCT06001086
Treatments Being Tested
In this single arm, open label, phase 2 trial, operable patients with stage...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2022-08-04
Trial ID
NCT05800756
Treatments Being Tested
This study is a prospective, single-arm, phase II clinical study for patien...
Status
Unknown
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05577923
Treatments Being Tested
This is a Phase 1, open-label study to evaluate the safety and the efficacy...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2021-07-28
Trial ID
NCT05016544
Treatments Being Tested
This study investigates the efficacy and safety of trastuzumab, pyrotinib c...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05577442
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
Pyrotinib is an oral tyrosine kinase inhibitor targeting both HER1, HER2 an...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2018-12-22
Trial ID
NCT03933982
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of Camrelizumab ...
Status
Unknown
Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Start Date
2021-12-31
Trial ID
NCT05111444
Treatments Being Tested
Patients with Stage II-III HER2-positive breast cancer will receive three c...
Status
Recruiting
Location
Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital
Start Date
2026-02-02
Trial ID
NCT07393425
This is an exploratory, single-arm, multi-center study to assess the effica...
Status
Not Yet Recruiting
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2024-01-30
Trial ID
NCT06245824
Treatments Being Tested